Melioidosis in the remote Katherine region of northern Australia.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
06 2022
Historique:
received: 21 01 2022
accepted: 10 05 2022
revised: 24 06 2022
pubmed: 14 6 2022
medline: 29 6 2022
entrez: 13 6 2022
Statut: epublish

Résumé

Melioidosis is endemic in the remote Katherine region of northern Australia. In a population with high rates of chronic disease, social inequities, and extreme remoteness, the impact of melioidosis is exacerbated by severe weather events and disproportionately affects First Nations Australians. All culture-confirmed melioidosis cases in the Katherine region of the Australian Top End between 1989-2021 were included in the study, and the clinical features and epidemiology were described. The diversity of Burkholderia pseudomallei strains in the region was investigated using genomic sequencing. From 1989-2021 there were 128 patients with melioidosis in the Katherine region. 96/128 (75%) patients were First Nations Australians, 72/128 (56%) were from a very remote region, 68/128 (53%) had diabetes, 57/128 (44%) had a history of hazardous alcohol consumption, and 11/128 (9%) died from melioidosis. There were 9 melioidosis cases attributable to the flooding of the Katherine River in January 1998; 7/9 flood-associated cases had cutaneous melioidosis, five of whom recalled an inoculating event injury sustained wading through flood waters or cleaning up after the flood. The 126 first-episode clinical B. pseudomallei isolates that underwent genomic sequencing belonged to 107 different sequence types and were highly diverse, reflecting the vast geographic area of the study region. In conclusion, melioidosis in the Katherine region disproportionately affects First Nations Australians with risk factors and is exacerbated by severe weather events. Diabetes management, public health intervention for hazardous alcohol consumption, provision of housing to address homelessness, and patient education on melioidosis prevention in First Nations languages should be prioritised.

Identifiants

pubmed: 35696415
doi: 10.1371/journal.pntd.0010486
pii: PNTD-D-22-00077
pmc: PMC9232150
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0010486

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Microbiol. 2017 Jan 23;2:16263
pubmed: 28112723
BMC Public Health. 2011 Sep 27;11:737
pubmed: 21951514
Int J Equity Health. 2013 Sep 13;12:79
pubmed: 24034417
Curr Trop Med Rep. 2017;4(4):185-191
pubmed: 29188170
J Infect. 2016 Jun;72(6):687-697
pubmed: 26945846
Appl Environ Microbiol. 2015 Nov 25;82(3):954-63
pubmed: 26607593
BMC Public Health. 2021 Oct 23;21(1):1921
pubmed: 34686162
N Engl J Med. 2012 Sep 13;367(11):1035-44
pubmed: 22970946
Mol Biol Evol. 2018 Dec 1;35(12):3041-3043
pubmed: 30351396
Sci Rep. 2020 Mar 25;10(1):5443
pubmed: 32214186
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
PLoS Negl Trop Dis. 2015 Jun 10;9(6):e0003834
pubmed: 26061639
Clin Infect Dis. 2008 Sep 1;47(5):603-9
pubmed: 18643756
PLoS Negl Trop Dis. 2021 Jun 25;15(6):e0009060
pubmed: 34170931
Int J Epidemiol. 2006 Apr;35(2):323-9
pubmed: 16326823
Lancet Infect Dis. 2021 Dec;21(12):1737-1746
pubmed: 34303419
Med J Aust. 2012 Mar 19;196(5):345-8
pubmed: 22432675
Aust N Z J Public Health. 2021 Apr;45(2):122-128
pubmed: 33522674
Sci Rep. 2018 Jun 6;8(1):8674
pubmed: 29875361
Int J Environ Res Public Health. 2019 Nov 06;16(22):
pubmed: 31698685
Int J Environ Health Res. 2022 Mar;32(3):487-502
pubmed: 32543219
PLoS Negl Trop Dis. 2020 Sep 28;14(9):e0008659
pubmed: 32986699
PLoS Negl Trop Dis. 2016 Jul 29;10(7):e0004823
pubmed: 27472421
Emerg Infect Dis. 2015 Jun;21(6):1038-40
pubmed: 25988301
Microb Genom. 2019 Aug;5(8):
pubmed: 31433287
PLoS Negl Trop Dis. 2021 Jun 21;15(6):e0009544
pubmed: 34153059
Semin Respir Crit Care Med. 2015 Feb;36(1):111-25
pubmed: 25643275

Auteurs

Kay Hodgetts (K)

Department of Infectious Diseases, Wellington Regional Hospital, Wellington, New Zealand.
Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.

Mariana Kleinecke (M)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Celeste Woerle (C)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Mirjam Kaestli (M)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Richard Budd (R)

Katherine District Hospital, Katherine, Northern Territory, Australia.

Jessica R Webb (JR)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.
Department of Microbiology & Immunology, The University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Linda Ward (L)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Mark Mayo (M)

Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Bart J Currie (BJ)

Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Ella M Meumann (EM)

Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH